These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14032963)

  • 1. [A case of severe hematological reaction following intake of Daraprim and Trisulfon].
    KIRCHEV I
    Suvr Med (Sofiia); 1962; 13(7)():31-3. PubMed ID: 14032963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow].
    Weissbach G
    Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects of combined toxoplasmosis therapy with daraprim and sulfonamides].
    Krüger E; Gerschke G
    Padiatr Grenzgeb; 1969; 8(1):39-48. PubMed ID: 5382580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Life-endangering hemorrhage after the treatment of toxoplasmosis with Daraprim and Supracid].
    Schröter RM
    Dtsch Gesundheitsw; 1966 Jan; 21(1):12-4. PubMed ID: 5939900
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of toxoplasmosis with pyrimethamine (daraprim) and triple sulfonamide.
    WETTINGFELD RF; ROWE J; EYLES DE
    Ann Intern Med; 1956 Mar; 44(3):557-64. PubMed ID: 13303028
    [No Abstract]   [Full Text] [Related]  

  • 6. [On hematological changes in daraprim therapy of toxoplasmosis].
    KOCH F; WOKITTEL E
    Z Kinderheilkd; 1959; 82():688-96. PubMed ID: 14410315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyrimethamine (daraprim) in therapy of human toxoplasmosis].
    PETROVICKY O; STYBLOVA V
    Cas Lek Cesk; 1955 Aug; 94(34-35):937-9. PubMed ID: 13261110
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of toxoplasmosis treated with Daraprim--a brief review of 28 cases in Japan].
    FUKUI A; OKADA T; TANAKA H; IKUZAWA M; JYONO K
    Shonika Kiyo; 1961; 7():254-62. PubMed ID: 13895819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intoxication with pyrimethamine (daraprim)].
    Nano HD; Plaza A
    Arch Oftalmol B Aires; 1967 Aug; 42(8):224-9. PubMed ID: 5596729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contributions to the problem of toxoplasmosis. I. Should we, at the present state of knowledge, treat pregnant women with positive toxoplasmosis titers, with daraprim and supronal?].
    ISBRUCH F
    Zentralbl Gynakol; 1960 Oct; 82():1522-44. PubMed ID: 13717959
    [No Abstract]   [Full Text] [Related]  

  • 11. TETRAGENESIS FROM DARAPRIM.
    SAND BJ; SHANEDLING PD
    Am J Ophthalmol; 1963 Dec; 56():1011-2. PubMed ID: 14088662
    [No Abstract]   [Full Text] [Related]  

  • 12. TOXOPLASMOSIS IN THE ADULT.
    SAUNDERS SJ; THATCHER GN
    S Afr Med J; 1963 Oct; 37():1026-9. PubMed ID: 14074809
    [No Abstract]   [Full Text] [Related]  

  • 13. The hematologic toxicity of pyrimethamine (daraprim) in man.
    KAUFMAN HE; GEISLER PH
    Arch Ophthalmol; 1960 Jul; 64():140-6. PubMed ID: 14404857
    [No Abstract]   [Full Text] [Related]  

  • 14. The chemotherapeutic efficacy of 2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine (daraprim) in experimental toxoplasmosis.
    SUMMERS WA
    Am J Trop Med Hyg; 1953 Nov; 2(6):1037-44. PubMed ID: 13104813
    [No Abstract]   [Full Text] [Related]  

  • 15. [Observations on daraprim and sulfonamide therapy of latent toxoplasmosis in women].
    FILIPOWSKA I; BARBAROWSKI H
    Wiad Parazytol; 1958; 4(3):193-6. PubMed ID: 13604126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contributions to the problem of toxoplasmosis. II. Studies on modification of the blood picture by daraprim-supronal-aureomycin therapy].
    ISBRUCH F
    Zentralbl Gynakol; 1961 May; 83():693-701. PubMed ID: 13717960
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and diagnosis of toxoplasmosis.
    KAUFMAN HE
    J Fla Med Assoc; 1963 Jan; 49():571-6. PubMed ID: 14031374
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation.
    Fricker-Hidalgo H; Brion JP; Durand M; Chavanon O; Brenier-Pinchart MP; Pelloux H
    Transpl Infect Dis; 2005 Mar; 7(1):38-40. PubMed ID: 15984948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.